Psychedelic medicine
Everything on psychedelic medicine: ketamine and esketamine, MDMA, psilocybin and more. What the trials show, what the risks are, and where the field is heading.
16 posts, 3 tools, 1 screener and 1 paper, last updated Oct 11, 2026. Short link: doctorreid.com/psychedelics
- The race to approve psilocybinUsona, Compass and why the first approval may matter less than what comes after itNov 2, 2026
- A fair test, in the wildReading a new JAMA trial of a short-acting nasal psychedelic, with the tools from the last postOct 30, 2026
- The problem child grows upEighty years of LSD in human research, from Hofmann's bicycle to phase 3Oct 24, 2026
- Psilocybin is my friendThe experiences that changed lives, and the numbers on when it goes badlyOct 24, 2026
- How to read a bloomA field guide to the receptor blooms, with ninety-five to play withOct 23, 2026
- Happy birthday, Dr. LearyWhat to keep and what to leave of Timothy Leary, on his birthdayOct 22, 2026
- Psilocybin may be coming to the Spravato clinicThe clock, the eight-hour day, the rooms, the people, the moneyOct 20, 2026
- Waking up is not growing upAdult development, the midlife passage, and the laundryOct 11, 2026
- Was it the pill?Placebo, nocebo, and how to tell what a medicine is really doingOct 6, 2026
- When the trip doesn't endHPPD: when visuals linger after psychedelics, and what helpsOct 5, 2026
- The hidden therapistHow music works inside a psychedelic sessionOct 5, 2026
- The life of an adverse eventHow a side effect becomes a line in the package insertOct 4, 2026
- How much of the change is the molecule?The drug, the therapist, or neither: what does the work?Oct 2, 2026
- The worry engineGeneralized anxiety and its relatives, with a self-check for eachOct 1, 2026
- Ketamine and the suicidal crisisRapid relief of suicidal thinking: what we know and don'tSep 21, 2026
- MDMA, measuredAn evidence-graded MDMA harm-reduction referenceSep 10, 2026
- Seeing ThingsWhy psilocybin, sleeplessness and a failing eye make the same visionsAug 24, 2026
- 4-OH-DiPT: a research reportThe shortest-acting oral psychedelic, now in trialsAug 4, 2026
- 5-MeO-DMT: a research reportThe toad molecule: biggest effect, shortest sessionAug 4, 2026
- MDMA: a research reportTwo positive trials, one FDA rejection, and what comes nextAug 4, 2026
- LSD: a research reportFrom counterculture to Phase 3 for anxietyAug 4, 2026
- Psilocybin and psilocin: a research reportWhere psilocybin stands on the road to approvalAug 4, 2026
- Methylone: a research reportA smoke-shop stimulant now in Phase 3 for PTSDAug 3, 2026
- The Compound LibraryFive molecules, one research report each: history, receptor binding, and where the trials stand.Tool
- Psychedelic experience scalesMeasures used in psychedelic trials.Screener
- The Institute for Inner SpaceA walk-through 3D museum of inner space.Tool
- Psychedelic Therapy Frontiers220+ episodes with Dr. Steve Thayer.Tool
- Ketamine, Esketamine, and SuicidalityThe full evidence, 25 references, as PDF and web.Paper
Related topics
Mind & perception, Psychopharmacology, Therapy, Mood & anxiety, Suicide prevention, PTSD & trauma
Other topics
Suicide prevention, Mind & perception, Therapy, Mood & anxiety, Psychopharmacology, ADHD & attention, PTSD & trauma, Body & health, Food & eating. Or see all posts, newest first.